Endo announces two key executive promotions

Ireland-incorporated drugmaker Endo International (Nasdaq: ENDP) today announced the appointment of two executive leadership team members.

Terrance Coughlin has been promoted to executive vice president and chief operating officer and Tony Pera has been named president of Par Pharmaceutical, which is Endo's US Generics operating company. Both appointments are effective November 1, 2016.

"I am excited and very pleased to add Terry and Tony to Endo's Executive Leadership Team and to continue to strengthen the management of the company," said Paul Campanelli, Endo’s president and chief executive, who himself only took on this post in September. "Terry has worked closely with me over the past 25 years as a partner and collaborator, most recently leading the operations of Par Pharmaceutical. Tony brings experience and expertise that will be tremendously valuable in effectively managing our US Generics business. They are both seasoned and trusted executives who consistently deliver results and I have tremendous confidence in their ability to help drive operational excellence and growth for Endo," Mr Campanelli added.